Sort by
Refine Your Search
-
Andrea Mennicken on the international project “Between Economy and Democracy: Reorganising Research Evaluation through Metadata in the Digital Era”, funded by the Open Research Area 8 Initiative through
-
pharmaceutical dermatology. They design of innovative pharmaceutical formulations and devices. They are interested in how therapeutic agents are released from formulations and how they cross biological barriers
-
this effect is exerted through the inhibition of lysyl oxidase and collagen cross-linking. The project has four main aims: 1) to determine whether extracellular TFGβ/BMP inhibitors increase cardiomyocyte
-
to how we understand mental health; - Work in partnership with affected communities. To help us complete this work, we are looking for 2x Research Associates to help ensure we meet our
-
of biochemical and biophysical technologies. The post holder will work alongside another PDRA employed on the project, who will be a radiochemist based primarily at Imperial College London. We are looking for a
-
work closely with the Principal Investigator (PI) Guillaume Conchon--Kerjan on the EPSRC project ‘New Phenomena for Random Walks in Dynamic Environments’ to deliver innovative research results in
-
work make a real-world impact? King’s College London is seeking a talented Postdoctoral Research Associate to join the pioneering NanoCure project, an ambitious programme developing medical-grade
-
computing. You will join the Vision & Human-Robot Interaction (VHR) Group, which brings together researchers working at the intersection of computer vision, robotics, and assistive technologies. The team is
-
, disease and stress-response contexts. The successful candidate will lead computational lab analysis work across multiple projects, largely focussing on the perturbation of skeletal muscle cells (myofibres
-
London Bridge station. About the role: We are seeking a motivated Postdoctoral Associate with an interest in primary headache disorders and related co-morbid conditions to help uncover novel disease